Depression and serum adiponectin and adipose omega-3 and omega-6 fatty acids in adolescents

Pharmacology Biochemistry and Behavior

Volumn 85, Issue 2, 2006, Pages 474-479

  Mamalakis, George ^a   Kiriakakis, Michael ^a   Tsibinos, George ^a   Hatzis, Christos ^a   Flouri, Sofia ^a   Mantzoros, Christos ^b   Kafatos, Anthony ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Adiponectin; Adipose tissue; Depression; Fish oil; Human; Omega 3 fatty acids; Psychological

Indexed keywords

ADIPONECTIN; DIHOMO GAMMA LINOLENIC ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID;

ADIPOSE TISSUE; ADOLESCENT; ADULT; ARTICLE; BECK DEPRESSION INVENTORY; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIETARY INTAKE; FEMALE; GAS CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; MULTIPLE REGRESSION; NORMAL HUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADIPONECTIN; ADIPOSE TISSUE; ADOLESCENT; CYTOKINES; DEPRESSION; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; HUMANS; LINEAR MODELS; MALE;

EID: 33845324873     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2006.10.008     Document Type: Article

References (72)

1. Adams P.B., Lawson S., Sanigorski A., and Sinclair A.J. Arachidonic to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression. Lipids 31 (1996) 157-161 [Suppl]
2. Barrera Jr. M., and Garrison-Jones C.V. Properties of the Beck Depression Inventory as a screening instrument for adolescent depression. J Abnorm Child Psychol 16 (1988) 263-273
3. Beck A.T., Ward C.H., Mendelson M., Mock J., and Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 4 (1961) 561-571
4. Bernstein E.L., Koutkia P., Ljungquist K., Breu J., Canavan B., and Grinspoon S. Acute regulation of adiponectin by free fatty acids. Metabolism 53 (2004) 790-793
5. Beynen A.C., and Katan M.B. Why do polyunsaturated fatty acids lower serum cholesterol?. Am J Clin Nutr 42 (1985) 560-563
6. Beynen A.C., Hermus R.J., and Hautvast J.G. A mathematical relationship between the fatty acid. Am J Clin Nutr 33 (1980) 81-85
7. Brachova L., Lue L.F., Schultz J., el Rashidy T., and Rogers J. Association cortex, cerebellum, and serum concentrations of C1q and factor B in Alzheimer's disease. Brain Res Mol Brain Res 18 (1993) 329-334
8. Calder P.C. n-3 polyunsaturated fatty acids and cytokine production in health and disease. Ann Nutr Metab 41 (1997) 203-234
9. Capuron L., Hauser P., Hinze-Selch D., Miller A.H., and Neveu P.J. Treatment of cytokine-induced depression. Brain Behav Immun 16 (2002) 575-580
10. Chabrol H., Montovany A., Chouicha K., and Duconge E. Study of the CES-D on a sample of 1,953 adolescent students. Encephale 28 5 Pt 1 (2002) 429-432
11. Dayton S., Hashimoto S., Dixon W., and Pearce M.L. Composition of lipids in human serum and adipose tissue during prolonged feeding of a diet high in unsaturated fat. J Lipids Res 7 (1966) 103-111
12. De Caterina R., Cybulsky M.I., Clinton S.K., Gimbrone Jr. M.A., and Libby P. The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. Arterioscler Thromb 14 (1994) 1829-1836
13. Delarue J., LeFoll C., Corporeau C., and Lucas D. N-3 long chain polyunsaturated fatty acids: a nutritional tool to prevent insulin resistance associated to type 2 diabetes and obesity?. Reprod Nutr Dev 44 (2004) 289-299
14. Edwards A.L. An introduction to linear regression and correlation (1984), W.H. Freeman and Co, New York 44-45
15. Edwards R., Peet M., Shay J., and Horrobin D. Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J Affect Disord 48 (1998) 149-155
16. Engeli S., Feldpausch M., Gorzelniak K., Hartwig F., Heintze U., Janke J., et al. Association between adiponectin and mediators of inflammation in obese women. Diabetes 52 (2003) 942-947
17. Fernandez-Real J.M., Vendrell J., and Ricart W. Circulating adiponectin and plasma fatty acid profile. Clin Chem 51 (2005) 603-609
18. Fountoulakis K., Iacovides A., Kleanthous S., Samolis S., Kaprinis S.G., Sitzoglou K., et al. Reliability, validity and psychometric properties of the Greek translation of the Center for Epidemiological Studies-Depression (CES-D) Scale. BMC Psychiatry 1 (2001) 3-8
19. Frommberger U.H., Bauer J., Haselbauer P., Fraulin A., Riemann D., and Berger M. Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission. Eur Arch Psychiatry Clin Neurosci 247 (1997) 228-233
20. Gannage-Yared M.H., Khalife S., Semaan M., Fares F., Jambart S., and Halaby G. Serum adiponectin and leptin levels in relation to the metabolic syndrome, androgenic profile and somatotropic axis in healthy non-diabetic elderly men. Eur J Endocrinol 155 (2006) 167-176
21. Gavrila A., Chan J.L., Yiannakouris N., Kontogianni M., Miller L.C., Orlova C., et al. Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: cross-sectional and interventional studies. J Clin Endocrinol Metab 88 (2003) 4823-4831
22. Hestad K.A., Tonseth S., Stoen C.D., Ueland T., and Aukrust P. Raised plasma levels of tumor necrosis factor alpha in patients with depression: normalization during electroconvulsive therapy. J ECT 19 (2003) 183-188
23. Hibbeln J.R. Fish consumption and major depression. Lancet 351 (1998) 1213
24. Kelley D.S., Taylor P.C., Nelson G.J., Schmidt P.C., Ferretti A., Erickson K.L., et al. Docosahexaenoic acid ingestion inhibits natural killer cell activity and production of inflammatory mediators in young healthy men. Lipids 34 (1999) 317-324
25. Kern P.A., Di Gregorio G.B., Lu T., Rassouli N., and Ranganathan G. Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes 52 (2003) 1779-1785
26. Khalfoun B., Thibault F., Watier H., Bardos P., and Lebranchu Y. Docosahexaenoic and eicosapentaenoic acids inhibit in vitro human endothelial cell production of interleukin-6. Adv Exp Med Biol 400 (1997) 589-597
27. Krakoff J., Funahashi T., Stehouwer C.D., Schalkwijk C.G., Tanaka S., Matsuzawa Y., et al. Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian. Diabetes Care 26 (2003) 1745-1751
28. Kubera M., Lin A.H., Kenis G., Bosmans E., van Bockstaele D., and Maes M. Anti-inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio. J Clin Psychopharmacol 21 (2001) 199-206
29. Kumada M., Kihara S., Ouchi N., Kobayashi H., Okamoto Y., Ohashi K., et al. Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. Circulation 109 (2004) 2046-2049
30. Lebas E., Paquot N., and Scheen A.J. Adiponectin: a new adipocytokine. Rev Med Liege 58 (2003) 554-558
31. Lewis-Barned N.J., Sutherland W.H., Walker R.J., de Jong S.A., Walker H.L., Edwards E.A., et al. Plasma cholesteryl ester fatty acid composition, insulin sensitivity, the menopause and hormone replacement therapy. J Endocrinol 165 (2000) 649-655
32. Lombardo Y.B., and Chicco A.G. Effects of dietary polyunsaturated n-3 fatty acids on dyslipidemia and insulin resistance in rodents and humans. A review. J Nutr Biochem 17 (2006) 1-13
33. Luo X., Weber G.A., Zheng J., Gendelman H.E., and Ikezu T. C1q-calreticulin induced oxidative neurotoxicity: relevance for the neuropathogenesis of Alzheimer's disease. J Neuroimmunol 135 (2003) 62-71
34. Maes M. Evidence for an immune response in major depression: a review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry 19 (1995) 11-38
35. Maes M., Bosmans E., Suy E., Vandervorst C., DeJonckheere C., and Raus J. Depression-related disturbances in mitogen-induced lymphocyte responses and interleukin-1 beta and soluble interleukin-2 receptor production. Acta Psychiatr Scand 84 (1991) 379-386
36. Maes M., Scharpe S., Meltzer H.Y., Bosmans E., Suy E., Calabrese J., et al. Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression. Psychiatry Res 49 (1993) 11-27
37. Maes M., Bosmans E., Meltzer H.Y., Scharpe S., and Suy E. Interleukin-1 beta: a putative mediator of HPA axis hyperactivity in major depression?. Am J Psychiatry 150 (1993) 1189-1193
38. Maes M., Stevens W.J., Declerck L.S., Bridts C.H., Peeters D., Schotte C., et al. Significantly increased expression of T-cell activation markers (interleukin-2 and HLA-DR) in depression: further evidence for an inflammatory process during that illness. Prog Neuro-Psychopharmacol Biol Psychiatry 17 (1993) 241-255
39. Maes M., Scharpe S., Meltzer H.Y., Okayli G., Bosmans E., D'Hondt P., et al. Increased neopterin and interferon-gamma secretion and lower availability of l-tryptophan in major depression: further evidence for an immune response. Psychiatr Res 54 (1994) 143-160
40. Maes M., Meltzer H.Y., Bosmans E., Bergmans R., Vandoolaeghe E., Ranjan R., et al. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affect Disord 34 (1995) 301-309
41. Maes M., Meltzer H.Y., Buckley P., and Bosmans E. Plasma-soluble interleukin-2 and transferrin receptor in schizophrenia and major depression. Eur Arch Psychiatry Clin Neurosci 244 (1995) 325-329
42. Maes M., Smith R., Christophe A., Cosyns P., Desnyder R., and Meltzer H. Fatty acid composition in major depression: decreased omega 3 fractions in cholesteryl esters and increased C20: 4 omega 6/C20:5 omega 3 ratio in cholesteryl esters and phospholipids. J Affect Disord 38 (1996) 35-46
43. Maes M., Christophe A., Delanghe J., Altamura C., Neels H., and Meltzer H.Y. Lowered omega-3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Res 85 (1999) 275-291
44. Maes M., Lin A.H., Delmeire L., Van Gastel A., Kenis G., De Jongh R., et al. Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder following accidental man-made traumatic events. Biol Psychiatry 45 (1999) 833-839
45. Mamalakis G., Tornaritis M., and Kafatos A. Depression and adipose essential polyunsaturated fatty acids. Prostaglandins Leukot Essent Fat Acids 67 (2002) 311-318
46. Mamalakis G., Kiriakakis M., Tsibinos G., and Kafatos A. Depression and adipose polyunsaturated fatty acids in the survivors of the Seven Countries Study population of Crete. Prostaglandins Leukot Essent Fat Acids 70 (2004) 495-501
47. Mamalakis G., Kiriakakis M., Tsibinos G., and Kafatos A. Depression and adipose polyunsaturated fatty acids in an adolescent group. Prostaglandins Leukot Essent Fat Acids 71 (2004) 289-294
48. Meydani S.N., Endres S., Woods M.M., Goldin B.R., Soo C., Morrill-Labrode A., et al. Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between young and older women. J Nutr 121 (1991) 547-555
49. Meydani S.N., Lichtenstein A.H., Cornwall S., Meydani M., Goldin B.R., Rasmussen H., et al. Immunologic effects of national cholesterol education panel step-2 diets with and without fish-derived N-3 fatty acid enrichment. J Clin Invest 92 (1993) 105-113
50. Musselman D.L., Miller A.H., Porter M.R., Manatunga A., Gao F., Penna S., et al. Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings. Am J Psychiatry 158 (2001) 1252-1257
51. Nakane Y., Ohta Y., Uchino J., Takada K., Yan H.Q., Wang X.D., et al. Comparative study of affective disorders in three Asian countries. Acta Psychiatr Scand 78 (1988) 698
52. Nemets B., Stahl Z., and Belmaker R.H. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry 159 (2002) 477-479
53. O'Brien S.M., Scott L.V., and Dinan T.G. Cytokines: abnormalities in major depression and implications for pharmacological treatment. Hum Psychopharmacol 19 (2004) 397-403
54. Okamoto Y., Arita Y., Nishida M., Muraguchi M., Ouchi N., Takahashi M., et al. An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Horm Metab Res 32 (2000) 47-50
55. Okamura F., Tashiro A., Utumi A., Imai T., Suchi T., Tamura D., et al. Insulin resistance in patients with depression and its changes during the clinical course of depression: minimal model analysis. Metabolism 49 (2000) 1255-12560
56. Ouchi N., Kihara S., Funahashi T., Matsuzawa Y., and Walsh K. Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol 14 (2003) 561-566
57. Owen B.M., Eccleston D., Ferrier I.N., and Young A.H. Raised levels of plasma interleukin-1beta in major and postviral depression. Acta Psychiatr Scand 103 (2001) 226-228
58. Parissis J.T., Adamopoulos S., Rigas A., Kostakis G., Karatzas D., Venetsanou K., et al. Comparison of circulating proinflammatory cytokines and soluble apoptosis mediators in patients with chronic heart failure with versus without symptoms of depression. Am J Cardiol 94 (2004) 1326-1328
59. Peet M., and Horrobin D.F. A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry 59 (2002) 913-919
60. Peet M., Murphy B., Shay J., and Horrobin D. Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry 43 (1998) 315-319
61. Purasiri P., Mckechnie A., Heys S.D., and Eremin O. Modulation in vitro of human natural cytotoxicity, lymphocyte proliferative response to mitogens and cytokine production by essential fatty acids. Immunology 92 (1997) 166-172
62. Radloff L.S. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1 (1977) 385-401
63. Stefan N., and Stumvoll M. Adiponectin-its role in metabolism and beyond. Horm Metab Res 34 (2002) 469-474
64. Stoll A.L., Severus W.E., Freeman M.P., Rueter S., Zboyan H.A., Diamond E., et al. Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry 56 (1999) 407-412
65. Su K.P., Huang S.Y., Chiu C.C., and Shen W.W. Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial. Eur Neuropsychopharmacol 13 (2003) 267-271
66. Tanskanen A., Hibbeln J.R., Tuomilehto J., Uutela A., Haukkala A., Viinamaki H., et al. Fish cnsumption and depressive symptoms in the general population in Finland. Psychiatr Serv 52 (2001) 529-531
67. Timonen M., Laakso M., Jokelainen J., Rajala U., Meyer-Rochow V.B., and Keinanen-Kiukaanniemi S. Insulin resistance and depression: cross sectional study. BMJ 330 (2005) 17-18
68. Vasseur F. Adiponectin and its receptors: partners contributing to the "vicious circle" leading to the metabolic syndrome?. Pharmacol Res 53 (2006) 478-481
69. Vessby B. Dietary fat and insulin action in humans. Br J Nutr 83 Suppl 1 (2000) 91-96
70. Vessby B., Tengblad S., and Lithell H. Insulin sensitivity is related to the fatty acid composition of serum lipids and skeletal muscle phospholipids in 70-year-old men. Diabetologia 37 (1994) 1044-1050
71. Xiao F.Y., and Lu F.E. Research advancement of adipocytokine adiponectin. Sheng Li Ke Xue Jin Zhan 34 (2003) 309-313
72. Yamauchi T., Kamon J., Ito Y., Tsuchida A., Yokomizo T., Kita S., et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423 (2003) 762-769